These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 16405108)

  • 1. Marinobufagenin, an endogenous inhibitor of alpha-1 Na/K-ATPase, is a novel factor in pathogenesis of diabetes mellitus.
    Bagrov YY; Manusova NB; Egorova IA; Frolova EV; Fedorova OV; Bagrov AY
    Dokl Biol Sci; 2005; 404():333-7. PubMed ID: 16405108
    [No Abstract]   [Full Text] [Related]  

  • 2. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
    Bagrov AY; Fedorova OV
    J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.
    Fedorova OV; Lakatta EG; Bagrov AY
    Circulation; 2000 Dec; 102(24):3009-14. PubMed ID: 11113054
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Marinobufagenin, an endogenous alpha-1 sodium pump ligand, in hypertensive Dahl salt-sensitive rats.
    Fedorova OV; Kolodkin NI; Agalakova NI; Lakatta EG; Bagrov AY
    Hypertension; 2001 Feb; 37(2 Pt 2):462-6. PubMed ID: 11230319
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Endogenous digitalis-like ligands and Na/K-ATPase inhibition in experimental diabetes mellitus.
    Bagrov YY; Manusova NB; Egorova IA; Fedorova OV; Bagrov AY
    Front Biosci; 2005 Sep; 10():2257-62. PubMed ID: 15970492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Binding of ouabain and marinobufagenin leads to different structural changes in Na,K-ATPase and depends on the enzyme conformation.
    Klimanova EA; Petrushanko IY; Mitkevich VA; Anashkina AA; Orlov SN; Makarov AA; Lopina OD
    FEBS Lett; 2015 Sep; 589(19 Pt B):2668-74. PubMed ID: 26297827
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Involvement of Na(+), K(+)-ATPase and endogenous digitalis-like compounds in depressive disorders.
    Goldstein I; Levy T; Galili D; Ovadia H; Yirmiya R; Rosen H; Lichtstein D
    Biol Psychiatry; 2006 Sep; 60(5):491-9. PubMed ID: 16712803
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Endogenous ligand of alpha(1) sodium pump, marinobufagenin, is a novel mediator of sodium chloride--dependent hypertension.
    Fedorova OV; Talan MI; Agalakova NI; Lakatta EG; Bagrov AY
    Circulation; 2002 Mar; 105(9):1122-7. PubMed ID: 11877366
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Na
    Singh SV; Fedorova OV; Wei W; Rosen H; Horesh N; Ilani A; Lichtstein D
    Int J Mol Sci; 2020 Aug; 21(16):. PubMed ID: 32824628
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of Na/K ATPase from rat aorta by two Na/K pump inhibitors, ouabain and marinobufagenin: evidence of interaction with different alpha-subunit isoforms.
    Fedorova OV; Bagrov AY
    Am J Hypertens; 1997 Aug; 10(8):929-35. PubMed ID: 9270089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bufodienolides as endogenous Na+, K+-ATPase inhibitors: biosynthesis in bovine and rat adrenals.
    Lichtstein D; Steinitz M; Gati I; Samuelov S; Deutsch J; Orly J
    Clin Exp Hypertens; 1998; 20(5-6):573-9. PubMed ID: 9682913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous marinobufagenin-like immunoreactive factor and Na+, K+ ATPase inhibition during voluntary hypoventilation.
    Bagrov AY; Fedorova OV; Austin-Lane JL; Dmitrieva RI; Anderson DE
    Hypertension; 1995 Nov; 26(5):781-8. PubMed ID: 7591018
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endogenous cardiotonic steroids.
    Schoner W
    Cell Mol Biol (Noisy-le-grand); 2001 Mar; 47(2):273-80. PubMed ID: 11355001
    [TBL] [Abstract][Full Text] [Related]  

  • 14. No evidence for a role in signal-transduction of Na+/K+-ATPase interaction with putative endogenous ouabain.
    Hansen O
    Eur J Biochem; 2003 May; 270(9):1916-9. PubMed ID: 12709049
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ANP differentially modulates marinobufagenin-induced sodium pump inhibition in kidney and aorta.
    Fedorova OV; Agalakova NI; Morrell CH; Lakatta EG; Bagrov AY
    Hypertension; 2006 Dec; 48(6):1160-8. PubMed ID: 17043158
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resibufogenin corrects hypertension in a rat model of human preeclampsia.
    Vu H; Ianosi-Irimie M; Danchuk S; Rabon E; Nogawa T; Kamano Y; Pettit GR; Wiese T; Puschett JB
    Exp Biol Med (Maywood); 2006 Feb; 231(2):215-20. PubMed ID: 16446498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plasma marinobufagenin-like and ouabain-like immunoreactivity during saline volume expansion in anesthetized dogs.
    Bagrov AY; Fedorova OV; Dmitrieva RI; French AW; Anderson DE
    Cardiovasc Res; 1996 Feb; 31(2):296-305. PubMed ID: 8730407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Involvement of ouabain (digitalis-like factor) in the pathogenesis of hypertension and hypertensive target-organ damage].
    Goto A; Yamada K
    Nihon Rinsho; 2004 Mar; 62 Suppl 3():169-73. PubMed ID: 15171364
    [No Abstract]   [Full Text] [Related]  

  • 19. Synthesis of an Endogenous Steroidal Na Pump Inhibitor Marinobufagenin, Implicated in Human Cardiovascular Diseases, Is Initiated by CYP27A1 via Bile Acid Pathway.
    Fedorova OV; Zernetkina VI; Shilova VY; Grigorova YN; Juhasz O; Wei W; Marshall CA; Lakatta EG; Bagrov AY
    Circ Cardiovasc Genet; 2015 Oct; 8(5):736-45. PubMed ID: 26374826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Endogenous and exogenous cardiac glycosides and their mechanisms of action.
    Schoner W; Scheiner-Bobis G
    Am J Cardiovasc Drugs; 2007; 7(3):173-89. PubMed ID: 17610345
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.